Emerald Health Therapeutics Inc. (EMHTF: OTCQX International) | Emerald Health Therapeutics’ Pure Sunfarms JV Reaches Q2 Sales of $32 Million, 78% EBITDA Margin, $0.65/Gram All-in Production Cost, and Third Consecutive Quarter of Profitability

OTC Markets Group – News, Filings & Corporate Actions

Pin It